<DOC>
	<DOCNO>NCT02768818</DOCNO>
	<brief_summary>The investigator aim evaluate effectiveness probiotic ingestion change maternal microbiota prevent gestational diabetes overweight obese woman . To achieve goal , obese ( BMI &gt; 30 kg/m^2 ) overweight ( BMI &gt; 25 kg/m^2 ) pregnant woman risk factor enrol study randomize supplementation probiotic VIVOMIXX® placebo . The endpoint study evaluate dietary supplementation probiotic VIVOMIXX® modifies maternal fecal microbiota ( bifidobacteria lactobacillus ) relate enzymatic activity ( alkaline sphingomyelinase alkaline phosphatase ) , link improvement intermediate metabolism ( positive Oral Glucose Tolerance Test 24-26 week ) .</brief_summary>
	<brief_title>Modulation Intestinal Flora With Probiotic VIVOMIXX™ Pregnant Women Risk Metabolic Complications</brief_title>
	<detailed_description>This prospective , multicenter , randomize , double-blind , placebo-controlled trial . 208 pregnant woman recruit center enrol follow : Women eligible participate , prior inform consent , randomize 2 capsule twice daily breakfast dinner randomization delivery . The box give patient cod blind investigator participant , contain either active ingredient ( VIVOMIXX® , mixture 112 billion eight strain capsule , namely Streptococcus thermophilus , bifidobacteria ( B. breve , B. longum , B. infantis ) lactobacillus ( L. paracasei , L. acidophilus , L. delbrueckii subsp bulgaricus , L. plantarum ) placebo . The protocol include screen visit ( Visit 1 ) 10-12 week , two visit pregnancy ( 26-28 weeks= Visit 2 , 36-38 weeks=Visit 3 ) postnatal visit ( 2-3 day delivery=Visit 4 ) . Eligible woman take two capsule twice daily ( 2 morning 2 evening ) . Patients randomly assign control VIVOMIXX® group . The study agent VIVOMIXX® well placebo supply `` Mendes SA '' whole study period . During Visit 1 ( 10-12 week ) write consent obtain , information expect benefit possible inconvenience related participation trial . Furthermore , eligible woman ask complete two questionnaire , one dietary habit one gastrointestinal symptom . The questionnaire gastrointestinal symptom submit patient visit . Height assess Visit 1 , follow parameter measure visit : weight , waits/hip circumference ratio , arterial blood pressure , plasma hemoglobin ( Hb ) , hematocrit ( Ht ) , fast glycemia , fast insulin fasting glycated hemoglobin ( HbA1c1 ) . A blood sample evaluation homocysteine take well urine faeces sample collect nuclear-magnetic-resonance ( NMR ) -based metabolomics intestinal microbiota analysis . Furthermore , Arm-band position monitor sleep physical activity one week visit . At Visit 2 3 data regard ultrasound examination ( Amniotic fluid index , abdominal circumference , cephalic circumference ratio ) also collect . Two-three day delivery ( Visit 4 ) data regard delivery ( mode delivery , gestational age delivery ) well newborn ( Apgar score , glycemia serum bilirubin ) collect . Moreover , sample colostrum ( NMR-based metabolomics , microbiota high performance liquid chromatography-mass spectrometry -HPLC/MS- vitamin analysis ) newborn faeces ( NMR-based metabolomics microbiota analysis ) sample collect .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Pregnancy Diabetics</mesh_term>
	<criteria>Women age 20 40 singleton pregnancy BMI recruitment &gt; 30 kg/m^2 BMI &gt; 25 kg/m^2 simultaneous presence least 1 follow risk factor : age &gt; 35 year , previous fetal macrosomia ( &gt; 4500gr ) , family history diabetes ( firstdegree relative type 2 diabetes mellitus ) , previous gestational diabetes mellitus . Adherence lifestyle prescription include dietary counsel physical activity stimulation Subjects require intervention addition lifestyle change woman diet habit much different Mediterranean area ( Central Africa , Asian , etc.. ) . In subgroup difficult obtain adherence diet prescription since cultural attitude dietary habit . Prepregnancy BMI &gt; 40 kg/m^2 Chronic hypertension Fasting glycemia first trimester &gt; 126 mg / dl random glycemia &gt; 200 mg/dl</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Maternal Obesity Complicating Pregnancy</keyword>
</DOC>